Madrazo-González Z, García-Barrasa A, Rodríguez-Lorenzo L, Rafecas-Renau A, Alonso-Fernández G
Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario de Bellvitge, Barcelona, España.
Med Intensiva. 2011 Jan-Feb;35(1):32-40. doi: 10.1016/j.medin.2010.03.013. Epub 2010 May 18.
Anemia is one of the most prevalent diseases in the general population and is a very frequently found condition in medical and surgical patients in all medical specialties. A good evaluation of its clinical impact and its therapeutic possibilities is essential. Allogenic blood transfusion is a useful procedure in anemia management, although it has important adverse effects. It is the responsibility of the clinician to know and to take into account all the available alternatives for the treatment of anemia. Blood transfusions, erythropoiesis-stimulating agents, iron therapy (oral and endovenous) and other therapeutic alternatives must be rationally used, in accordance with the currently available clinical evidence. This review article summarizes some epidemiological characteristics of anemia, its clinical evaluation and the main therapeutic possibilities based on the present knowledge, placing special emphasis on the critically ill patient.
贫血是普通人群中最常见的疾病之一,也是所有医学专科中在内科和外科患者中非常常见的病症。对其临床影响和治疗可能性进行良好评估至关重要。异体输血在贫血管理中是一种有用的方法,尽管它有重要的不良反应。临床医生有责任了解并考虑到治疗贫血的所有可用替代方案。输血、促红细胞生成素、铁剂治疗(口服和静脉内)以及其他治疗替代方案必须根据当前可用的临床证据合理使用。这篇综述文章总结了贫血的一些流行病学特征、其临床评估以及基于现有知识的主要治疗可能性,特别强调了危重症患者。